Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ACOR - Acorda Therapeutics GAAP EPS of -$0.57 revenue of $33.51M

ACOR - Acorda Therapeutics GAAP EPS of -$0.57 revenue of $33.51M

Acorda Therapeutics Inc.
  • Acorda Therapeutics press release ( NASDAQ: ACOR ): Q3 GAAP EPS of -$0.57.
  • Revenue of $33.51M (+6.5% Y/Y).
  • Shares +1.2% .
  • INBRIJA (levodopa inhalation powder) Q3 2022 U.S. net revenue of $7.8 million; 1% increase over Q3 2021
  • AMPYRA (dalfampridine) Q3 2022 net revenue of $21.1 million; 5% increase over Q3 2021
  • $16.5M award and royalty/supply relief in AMPYRA arbitration case

For further details see:

Acorda Therapeutics GAAP EPS of -$0.57, revenue of $33.51M
Stock Information
Company Name: Acorda Therapeutics Inc.
Stock Symbol: ACOR
Market: NASDAQ
Website: acorda.com
Menu
ACOR ACOR Quote ACOR Short ACOR News ACOR Articles ACOR Message Board
Get ACOR Alerts

News, Short Squeeze, Breakout and More Instantly...